English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
Novotech Wins CRO Contract for Komipharm Coronavirus Covid-19 Clinical Trial in South Korea
Mar 06, 2020 22:00 HKT
AIM ImmunoTech joins with ChinaGoAbroad for Ampligen China Entry against COVID-19
Feb 27, 2020 19:30 HKT
NanoViricides has filed Quarterly Report for period ending December 31, 2019; Sufficient Cash, HerpeCide(TM) Drug Candidate IND Application Development in Progress
Feb 27, 2020 09:00 HKT
Captiva Verde Land Corp - Corporate Update
Feb 27, 2020 07:00 HKT
Oxford Medical Case shows Chiropractics can ease Dizziness and Neck Pain
Feb 26, 2020 14:00 HKT
Aptorum Group Commences Commercialization of Dioscorea Opposita Bioactive Nutraceutical Tablets and Signed Sales Distribution Agreement in Hong Kong
Feb 24, 2020 20:13 HKT
Viva Biotech Included as Constituent Stock of Hang Seng Composite Index and Other 6 Indexes, Becoming an Eligible Stock of Shenzhen-Hong Kong Stock Connect
Feb 24, 2020 07:32 HKT
The Strength and Potential of China Medical System (867.HK) Reflected in an Untenable Short Selling Attack
Feb 20, 2020 17:04 HKT
Holista Partners GICC LLC, the U.S. Developer of Path-Away(R), to Co-Develop Nasal Sanitising Balm for Global Markets
Feb 20, 2020 16:00 HKT
DNX Biopharmaceuticals Announces Collaboration with Lung Cancer Initiative at Johnson & Johnson
Feb 19, 2020 00:00 HKT
AIM ImmunoTech Issues Stockholder Update on the Potential Role of Ampligen for Use Against the Wuhan Coronavirus Epidemic
Feb 18, 2020 19:30 HKT
Blue Orca's Short Selling Plan Failed Because the Quality China Medical System (867.HK) Can Withstand Severe Tests
Feb 14, 2020 18:00 HKT
China Medical System (867.HK) Armed against Short Selling! The Biggest CSO Took Control of Full Industrial Chain
Feb 14, 2020 17:25 HKT
Hua Medicine appoints Dr. Fuxing Tang, a former U.S. FDA Officer, as Chief Technology Officer
Feb 14, 2020 15:21 HKT
AIM ImmunoTech Files Three Provisional Patent Applications Surrounding Ampligen(R) for Use Against the SARS-like Wuhan 2019 Novel Coronavirus
Feb 11, 2020 19:30 HKT
Aptorum Group Announces Further Positive Data for its ALS-4 Small Molecule Anti-virulence (Non-bactericidal) Drug Candidate for Treatment of Infections caused by Staphylococcus Aureus
Feb 11, 2020 11:14 HKT
Bayer, Meiogenix Collaborate to Accelerate Agricultural Innovation Through the Development of Unique Technologies
Feb 10, 2020 15:00 HKT
Malaysians Rush for Anti-Virus Sanitiser, NatShield(TM), after Pharmacies Restock on Concerns of Spread of Deadly Disease
Feb 06, 2020 16:00 HKT
Livingstone Health Unveils New Corporate Identity; Adds Cardiology and Family Medicine Capabilities
Feb 06, 2020 13:00 HKT
Swallowing difficulty may be caused by spinal disease, says study by Hong Kong Chiropractors
Feb 03, 2020 17:00 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: